Featured News

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).

On April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.

The Celiac Disease Foundation is matching donations, dollar for dollar, up to $25,000. Together we can protect those with celiac disease in crisis. 

To share with you some insight into our advocacy work, I recently interviewed Mark Van de Water, Senior Advisor at Baker Donelson.

Researchers found that children initially diagnosed with potential celiac disease had a high risk of developing celiac disease.

A few highlights from research studies published in peer-reviewed journals in the last few months are products of the research grants CDF awarded.

The Celiac Disease Foundation announces its newest appointee, Casey Guber, to its Board of Directors.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

Thanks to your support, we have been remarkably successful in advancing our shared mission over the past year. What follows are some highlights of some of our most important accomplishments.